$AQB Income Statement | Understand Stock

$AQB

$1.08 -$0.07 (6.09%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Product revenues
Costs and expenses
Product costs
Sales and marketing
Research and development
General and administrative
Long-lived asset impairment
Asset impairment, net
Total costs and expenses
Operating loss
Other income (expense)
Interest expense
Loan forgiveness
Other expense, net
Total other income (expense)
Loss from continuing operations
Loss from discontinued operations
Net loss
Other comprehensive income (loss)
Foreign currency gain (loss)
Unrealized gains (losses) on marketable securities
Unrealized gains on marketable securities
Total other comprehensive income (loss)

Comprehensive loss
Basic and diluted net loss per share
Weighted average number of common shares - basic and diluted
Basic and diluted net loss per share
Net loss from continuing operation, per share, basic
Net loss from continuing operation, per share, diluted
Net loss from discontinued operation, per share, basic
Net loss from discontinued operation, per share, diluted
Total basic net loss per share
Total diluted net loss per share
Weighted average number of common shares -
Weighted average number of shares outstanding, basic
Weighted average number of shares outstanding, diluted

Comments